TrialJournal of the American Society of Nephrology : JASN2020

Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.

Meghan E Sise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.